Idorsia presented the following eight posters at the World Sleep Society Congress 2025:
Scientific Content
- Real-world data on the abuse potential of medications for the treatment of insomnia
- Efficacy and safety of daridorexant in women with insomnia disorder during menopausal transition: a subgroup analysis
- Efficacy and safety of daridorexant in patients with chronic insomnia disorder and comorbid nocturia
- Effect of daridorexant on wakefulness throughout the night and morning sleepiness in patients with insomnia disorder
- Effect of daridorexant on wakefulness throughout the night: Post hoc analysis of a randomised, double-blind, active reference (zolpidem) study in patients with insomnia disorder
- The impact of insomnia disorder on the night and the day: analysis of polysomnography and subjective parameters from a large clinical trial database
- The impact of insomnia disorder on the night and the day in older and younger adults
- The impact of insomnia disorder on the night and the day in males and females
Symposium
Managing insomnia disorder in patients with neurological and
psychiatric comorbidities
September 5 -10. 2025, Singapore
David Neubauer (Chair)
Johns Hopkins School of Medicine
Baltimore, United States
Lu Lin (Co-Chair)
Peking Univerity
Beijing, China
.jpg)
Laura Palagini
University of Pisa
Pisa, Italy
Atul Khullar
University of Alberta and Med Sleep
Edmonton, Canada
Claudio Liguori
University of Rome Tor Vergata
Rome , Italy
